Canaccord Genuity Reiterates Their Buy Rating on Jamieson Wellness Inc

In a new note to investors today, an analyst has provided a rating update for the NA sector company, Jamieson Wellness Inc (TSX: JWEL). The company received a Buy rating from Canaccord Genuity’s analyst Derek Dley, with a C$26 price target.

Dley has an average return of 15.7% when recommending Jamieson Wellness Inc.

According to TipRanks.com, Dley is ranked #532 out of 4787 analysts.

Read also: vTv Therapeutics (VTVT) Stock: Healthcare Analysts Move to the Sidelines

Currently, the analyst consensus on Jamieson Wellness Inc is Strong Buy and the average price target is C$25.50, representing a 7.9% upside.

In a report issued on April 24, Scotiabank also maintained a Buy rating on the stock with a C$26 price target.

Based on Jamieson Wellness Inc’s latest earnings release for the quarter ending December 31, the company reported a quarterly net profit of C$3.73 million. In comparison, last year the company had a GAAP net loss of C$21.65 million.

Jamieson Wellness, Inc. engages in the manufacture and sale of sports nutrition products and specialty supplements. It operates through the Jamieson Brands and Strategic Partners segments. The Jamieson Brands segment comprises manufacture, distribution, and marketing of branded natural health products including vitamins, minerals, and supplements.

The company’s shares closed on Wednesday at C$23.64, close to its 52-week high of C$24.49.